TEVA Pharmaceutical Industries is preparing euro and dollar senior notes whose proceeds are intended to fund conditional redemptions of up to $450,000,000 of 2027 USD notes and €1,250,000,000 of 2030 Euro notes. Investors have defined Redemption conditions, while final transaction terms remain subject to completion.
Key Highlights
- The proposed notes include euro maturities in 2033 and 2036, plus dollar maturities in 2032, 2034 and 2037.
- Conditional redemptions cover all outstanding 2028 USD, 2029 USD and 2029 Euro notes.
- Historical cash and cash equivalents stood at $3,655 million on June 30, 2026.
TEVA Pharmaceutical Industries Ltd. (NYSE: TEVA) is preparing a euro- and dollar-denominated senior notes offering intended to support conditional redemptions, including up to $450,000,000 in principal amount of 2027 USD notes. The redemption plan also covers up to €1,250,000,000 in principal amount of 2030 Euro notes. The transaction remains preliminary, and its definitive terms may change.
Proposed Notes
and Redemption Terms The proposed securities include euro senior notes due 2033 and 2036, alongside dollar senior notes due 2032, 2034 and 2037. Teva intends to use net proceeds, together with cash on hand, to fund the conditional redemptions, pay related fees and expenses, and apply any remaining funds to general corporate purposes, including Debt repayment at maturity, through a tender offer or earlier redemption. The conditional redemptions would include all outstanding 2028 USD notes, 2029 USD notes and 2029 Euro notes. The plan also includes up to $450,000,000 of the 2027 USD notes and up to €1,250,000,000 of the 2030 Euro notes. Completion of the redemptions depends on the offering closing, while the offering itself does not depend on the redemptions. The euro notes would be issued in minimum denominations of €100,000, with whole multiples of €1,000 above that threshold. The dollar notes would have minimum denominations of $200,000, with whole multiples of $1,000 above $200,000. Teva reported cash and cash equivalents of $3,655 million as of June 30, 2026.



Please wait processing your request...